MARC details
000 -LEADER |
fixed length control field |
02529cas a2200529 a 4500 |
001 - CONTROL NUMBER |
control field |
11284173 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
000004 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220906184639.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
t| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
830610d19832007mduar 0 a0eng c |
022 0# - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
1045-8298 |
Source |
1 |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 736 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615/.1 |
Edition number |
15th |
210 0# - ABBREVIATED TITLE |
Abbreviated title |
USP DI |
245 00 - TITLE STATEMENT |
Title |
USP DI. Approved drug products and legal requirements. |
246 30 - VARYING FORM OF TITLE |
Title proper/short title |
Advice for the patient |
246 3# - VARYING FORM OF TITLE |
Title proper/short title |
United States pharmacopeia dispensing information. Approved drug products and legal requirements. |
246 3# - VARYING FORM OF TITLE |
Title proper/short title |
USP DI. |
Number of part/section of a work |
Vol. III, |
Name of part/section of a work |
Advice for the patient |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Rockville, Md. : |
Name of publisher, distributor, etc. |
United States Pharmacopeial Convention, |
Date of publication, distribution, etc. |
c1995. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
v. : |
Dimensions |
28 cm. |
515 ## - NUMBERING PECULIARITIES NOTE |
Numbering peculiarities note |
Advice for the patient section called also v. 2. |
580 ## - LINKING ENTRY COMPLEXITY NOTE |
Linking entry complexity note |
Updated bimonthly by: USP DI update. |
580 ## - LINKING ENTRY COMPLEXITY NOTE |
Linking entry complexity note |
Published simultaneously with: USP DI. Drug information for the health care provider, and: USP DI. Vol. III, Approved drug products and legal requirements, and: The Complete drug reference. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
SERBIB/SERLOC merged record |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
Form subdivision |
Periodicals. |
9 (RLIN) |
2402 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemotherapy |
Form subdivision |
Periodicals. |
9 (RLIN) |
2403 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Therapy |
Form subdivision |
Periodicals. |
9 (RLIN) |
2490 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Therapy |
Form subdivision |
Popular Works. |
9 (RLIN) |
2491 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical Preparations |
Form subdivision |
Periodicals. |
9 (RLIN) |
2492 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical Preparations |
Form subdivision |
Popular Works. |
9 (RLIN) |
2493 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacopées |
Geographic subdivision |
États-Unis |
Form subdivision |
Périodiques. |
9 (RLIN) |
2406 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Médicaments |
General subdivision |
Administration |
Form subdivision |
Périodiques. |
9 (RLIN) |
2408 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Médicaments |
General subdivision |
Effets secondaires |
Form subdivision |
Périodiques. |
9 (RLIN) |
2409 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Médicaments |
Geographic subdivision |
États-Unis |
Form subdivision |
Périodiques. |
9 (RLIN) |
2407 |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Online databases. |
9 (RLIN) |
2494 |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
United States Pharmacopeial Convention. |
9 (RLIN) |
2495 |
770 1# - SUPPLEMENT/SPECIAL ISSUE ENTRY |
Title |
USP DI update |
International Standard Serial Number |
0730-1324 |
Record control number |
(DLC)sn 81006165 |
-- |
(OCoLC)5995439 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Title |
USP DI. Advice for the patient |
Record control number |
(OCoLC)595267118 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Online version: |
Title |
USP DI. Advice for the patient |
Record control number |
(OCoLC)607918335 |
780 01 - PRECEDING ENTRY |
Title |
United States pharmacopeia dispensing information |
International Standard Serial Number |
0276-5373 |
Record control number |
(DLC) 81640842 |
-- |
(OCoLC)5984533 |
787 1# - OTHER RELATIONSHIP ENTRY |
Title |
USP DI. Drug information for the health care provider |
International Standard Serial Number |
0740-4174 |
Record control number |
(DLC) 84642138 |
-- |
(OCoLC)8796116 |
787 1# - OTHER RELATIONSHIP ENTRY |
Title |
USP DI. Vol. III, Approved drug products and legal requirements |
International Standard Serial Number |
1045-8298 |
Record control number |
(DLC) 89646309 |
-- |
(OCoLC)19491595 |
787 1# - OTHER RELATIONSHIP ENTRY |
Title |
Complete drug reference |
Record control number |
(DLC)sn 91037304 |
-- |
(OCoLC)23070944 |
856 ## - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="http://nhrc.org.np/contact">http://nhrc.org.np/contact</a> |
Link text |
Visit NHRC Library |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
Books |